Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Age-dependent distribution of AKI risk factors

Published byLucinda Williams Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 1. Age-dependent distribution of AKI risk factors"— Presentation transcript:

1 Fig. 1. Age-dependent distribution of AKI risk factors
Fig. 1. Age-dependent distribution of AKI risk factors. (A) The average number of AKI risk factors by indicated age groups with the error bars representing the standard deviation. (B) The percentage of patients in each age group with no risk factors and (C) the percentage of the total patient cohort within each age group. From: Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk? Clin Kidney J. 2015;8(6): doi: /ckj/sfv080 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

2 Fig. 2. (A) Age-dependent distribution of patients at high risk of AKI
Fig. 2. (A) Age-dependent distribution of patients at high risk of AKI. High risk of AKI was defined as the presence of two or more fixed patient-related AKI risk factors. (B) Individual AKI risk factor (AKI-R) distribution. (B) Percentage of patients (solid black bars), patients ≥65 years of age (grey bars) or patients <65 years of age (open bars), positive for each of the individual fixed patient-related AKI risk factors. DM, diabetes mellitus; CKD, chronic kidney disease; BP, hypertension; IHD, ischaemic heart disease; CCF, congestive cardiac failure; CVD, cerebrovascular disease; PVD, peripheral vascular disease; Ob, morbid obesity; LD, liver disease; Neuro, neurological or cognitive impairment; AIDS, known diagnosis of AIDS; ACEi, angiotensin converting enzyme inhibitor; D, prescription of diuretic; NSAID, prescription of non-steroidal anti-inflammatory drugs). From: Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk? Clin Kidney J. 2015;8(6): doi: /ckj/sfv080 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

3 Fig. 3. Distribution of AKI risk factors (AKI-R) in HA- (solid bars) and CA-AKI (open bars). The data are expressed as a percentage of patients from either cohort. For significance, the appropriate P-value is shown. For each risk factor when no P-value is listed, the differences were not statistically significant. From: Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk? Clin Kidney J. 2015;8(6): doi: /ckj/sfv080 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

4 Fig. 4. Receiver operator characteristic curve for AKI prediction score for the whole cohort of patients using the AKI risk factors excluding age (A) or age alone (B), compared with the HA-AKI cohort using the AKI risk factors excluding age (C) or age alone (D) and the CA-AKI cohort using the AKI risk factors excluding age (E) or age alone (F). Solid line: prediction score, dashed line, reference line. From: Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk? Clin Kidney J. 2015;8(6): doi: /ckj/sfv080 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

Download ppt "Fig. 1. Age-dependent distribution of AKI risk factors"

Similar presentations

Figure 1 Alcohol consumption. A

Figure 1 Alcohol consumption. A
Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.

Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.
Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±

FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±
Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.

Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.
From: Dynamic De/Centralization in Canada, 1867–2010

From: Dynamic De/Centralization in Canada, 1867–2010
Figure 3: (a and b) Preoperative contrast-eCT

Figure 3: (a and b) Preoperative contrast-eCT
Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.

Figure 1. Unified models predicting gene regulation based on landscapes of gene-regulating factors. For each gene, position specific combinatorial patterns.
Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.

Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.
Figure 2. Number of cases required in a Mendelian randomization analysis with a binary outcome and a single instrumental variable for 80% power with a.

Figure 2. Number of cases required in a Mendelian randomization analysis with a binary outcome and a single instrumental variable for 80% power with a.
J Exp Bot. 2017;68(17): doi: /jxb/erx352

J Exp Bot. 2017;68(17): doi: /jxb/erx352
Figure 2. Chronic kidney disease risk tool application.

Figure 2. Chronic kidney disease risk tool application.
Fig. 1. Scheme for classifying renal function without access to laboratory test results. *Renal-specific drugs: phosphate binders (ATC codes.

Fig. 1. Scheme for classifying renal function without access to laboratory test results. *Renal-specific drugs: phosphate binders (ATC codes.
Fig 1 The CONSORT participant flow diagram for primary endpoints.

Fig 1 The CONSORT participant flow diagram for primary endpoints.
Figure 1. An example of an original simulation film used during the 1960s to 1990s to plan radiotherapy for Hodgkin lymphoma, with field borders marked.

Figure 1. An example of an original simulation film used during the 1960s to 1990s to plan radiotherapy for Hodgkin lymphoma, with field borders marked.
Figure 1 Study flow chart.

Figure 1 Study flow chart.
Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.

Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.
From: Learning by Working in Big Cities

From: Learning by Working in Big Cities
Figure 1 Boxes represent effect estimates and lines represent 95% confidence intervals. (A) Effect of evolocumab on the risk of major vascular events [cardiovascular.

Figure 1 Boxes represent effect estimates and lines represent 95% confidence intervals. (A) Effect of evolocumab on the risk of major vascular events [cardiovascular.
From: THE FALLACIES OF PATENT-HOLDUP THEORY

From: THE FALLACIES OF PATENT-HOLDUP THEORY

Similar presentations

Ads by Google